Chorionic Gonadotropin Market Report 2026

Chorionic Gonadotropin Market Overview

• The Chorionic Gonadotropin market growth in the historic period has been driven by growth of infertility treatments, established role in ovulation induction • Market expansion is supported by rising infertility rates globally, expansion of assisted reproductive technologies • Growth Driver: Rising Infertility Rates Driving Growth Of The Chorionic Gonadotropin Market • Market Trend: Innovative Saliva-Based Pregnancy Tests Transforming The Chorionic Gonadotropin Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Chorionic Gonadotropin Market?

Chorionic gonadotropin, specifically human chorionic gonadotropin (hCG), is a hormone produced by the placenta during pregnancy that supports the corpus luteum to maintain progesterone levels. It is used in medical treatments to induce ovulation in women, treat hypogonadism in men, and as a tumor marker for certain cancers. The main types of chorionic gonadotropin are human chorionic gonadotropin and animal chorionic gonadotropin. Human chorionic gonadotropin (hCG) is a hormone primarily produced during pregnancy by cells that form the placenta, which nourishes the fertilized egg after it has attached to the uterine wall. It was distributed through various channels, including hospital pharmacies, retail pharmacies, and online pharmacies, for various therapeutic applications, such as male hypogonadism, female infertility treatment, oligospermic treatment, cryptorchidism treatment, chronic pain, and others. It includes end users such as research institutions and pharmaceutical companies.

What Is The Chorionic Gonadotropin Market Growth Forecast?

The chorionic gonadotropin market size is expected to see strong growth in the next few years. It will grow to $1.82 million in 2030 at a compound annual growth rate (CAGR) of 6.2%. The growth in the forecast period can be attributed to rising infertility rates globally, expansion of assisted reproductive technologies, growing awareness of male hormonal disorders, increased oncology diagnostic applications, wider availability through retail pharmacies. Major trends in the forecast period include rising use in assisted reproductive treatments, growing application in male hypogonadism therapy, increased demand for fertility hormone therapies, expansion of diagnostic use as tumor marker, improved formulations and dosage accuracy.

What Are The Drivers Of The Chorionic Gonadotropin Market?

Increasing prevalence of infertility issues is expected to propel the growth of the chorionic gonadotropin market going forward. Infertility refers to the inability to conceive a child after one year of regular, unprotected sexual intercourse for couples under 35 years of age or after six months for couples 35 years and older. The rising prevalence of infertility is largely due to delayed childbearing, as many individuals choose to have children later in life, and lifestyle factors such as obesity and smoking, which can negatively impact reproductive health. Chorionic Gonadotropin (hCG) is used in fertility treatments to induce ovulation in women, support the luteal phase for pregnancy maintenance, and stimulate testosterone production in men to improve sperm count, addressing various infertility issues. For instance, in April 2023, according to the World Health Organization (WHO), a Switzerland-based specialized agency, approximately 17.5% of the adult population, or 1 in 6 people worldwide, experience infertility, underscoring the urgent need to improve access to affordable, high-quality fertility care for those affected. Therefore, increasing prevalence of infertility issues is driving the growth of the chorionic gonadotropin industry. An increase in assisted reproductive technologies is expected to propel the growth of the chorionic gonadotropin market going forward. Assisted reproductive technologies (ART) refer to medical procedures used to help individuals or couples achieve pregnancy when they are unable to do so naturally. The rise in assisted reproductive technologies (ART) is due to higher infertility rates, medical advancements, delayed childbearing, and increased accessibility. Chorionic gonadotropin (hCG) is used in assisted reproductive technologies to trigger ovulation and support the luteal phase after embryo transfer to ensure successful fertilization and early pregnancy. For instance, in May 2024, according to Cofertility, a US-based healthcare company, reported that demand for egg freezing is surging, with cycle numbers rising by almost 40% from 2022 to 2023. Therefore, the increase in assisted reproductive technologies is driving the growth of the chorionic gonadotropin industry.

Key Players In The Global Chorionic Gonadotropin Market

Major companies operating in the chorionic gonadotropin market are Ferring Pharmaceuticals

Global Chorionic Gonadotropin Market Trends and Insights

Major companies operating in the chorionic gonadotropin market are focusing on developing innovative solutions, such as saliva-based pregnancy tests, to improve convenience, accuracy, and accessibility. A saliva-based pregnancy test refers to a non-invasive diagnostic method that detects pregnancy by analyzing a woman's saliva for the presence of human chorionic gonadotropin (hCG), a hormone produced during pregnancy. For instance, in June 2023, Salignostics, an Israel-based biotech company, launched as the world's first saliva-based pregnancy test. his innovative product allows women to determine pregnancy using a saliva sample instead of urine, detecting the hormone hCG (human chorionic gonadotropin) with results available in just 5 to 15 minutes. Salistick offers a more comfortable and convenient testing experience, enabling users to test anywhere and share the moment with partners or loved ones.

What Defines the Chorionic Gonadotropin Market?

The chorionic gonadotropin market consists of sales of products including follicle-stimulating hormone, luteinizing hormone, menotropins, gonadotropin-releasing hormone, and clomiphene citrate. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Chorionic Gonadotropin Market Report 2026?

The chorionic gonadotropin market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the chorionic gonadotropin industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.